West Pharmaceutical Services, Inc.WSTNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.0%
5Y CAGR+6.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+9.0%/yr
vs +6.5%/yr prior
5Y CAGR
+6.8%/yr
Consistent
Acceleration
+2.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $485.90M | +19.2% |
| 2024 | $407.60M | -3.4% |
| 2023 | $421.80M | +12.4% |
| 2022 | $375.40M | -9.5% |
| 2021 | $414.70M | +18.9% |
| 2020 | $348.90M | +12.0% |
| 2019 | $311.60M | +6.9% |
| 2018 | $291.50M | +2.2% |
| 2017 | $285.10M | -0.1% |
| 2016 | $285.50M | - |